Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).

Br J Cancer · 2000 · PMC2363468 · PMID 11189100

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

of borderline significanceP = 0.11not close (p > 0.1)

The effect of neoadjuvant chemotherapy on event-free survival was smaller and of borderline significance ( P = 0.11).

also in 1,681 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.